Uploaded June 2026 | Updated September 2026, 3 weeks ago
At Mayo Clinic, neuroscientists are seeking to understand — and ultimately restore — brain function through advanced computational tools, neuromodulation technologies and multidisciplinary collaboration.
These new efforts are led by Gelareh Zadeh, M.D., Ph.D., a neurosurgeon and scientist. Dr. Zadeh specializes in neuro-oncology and has clinical expertise in treating brain tumors such as gliomas and meningiomas. Her research focuses on the molecular and genomic landscape of these tumors to advance precision medicine and improve targeted therapies.
Dr. Zadeh is the David C. and Flora C. Pratt Distinguished Chief Medical Officer for Mayo Clinic Platform, Department of Neurologic Surgery chair at Mayo Clinic in Rochester and the William J. and Charles H. Mayo Professor I of neurosurgery at Mayo Clinic College of Medicine and Science. She is also one of the leaders of the Bioelectronics Neuromodulation Innovation to Cure (BIONIC) initiative, which aims to advance care for complex neurological conditions by uniting clinical insight with cutting-edge engineering to deliver novel diagnostics and therapies.
In this conversation, Dr. Zadeh reflects on the path that led her to neurosurgery, what inspires her and why she believes the medical field is at a turning point in its ability to diagnose, treat and even prevent neurodegenerative diseases.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. newsnetwork.mayoclinic.org
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at newsnetwork.mayoclinic.org/request-account
Mayo Clinic: mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: facebook.com/MayoClinic
Follow Mayo Clinic on Instagram instagram.com/mayoclinic
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: threads.net/@mayoclinic
At Mayo Clinic, neuroscientists are seeking to understand — and ultimately restore — brain function through advanced computational tools, neuromodulation technologies and multidisciplinary collaboration.
These new efforts are led by Gelareh Zadeh, M.D., Ph.D., a neurosurgeon and scientist. Dr. Zadeh specializes in neuro-oncology and has clinical expertise in treating brain tumors such as gliomas and meningiomas. Her research focuses on the molecular and genomic landscape of these tumors to advance precision medicine and improve targeted therapies.
Dr. Zadeh is the David C. and Flora C. Pratt Distinguished Chief Medical Officer for Mayo Clinic Platform, Department of Neurologic Surgery chair at Mayo Clinic in Rochester and the William J. and Charles H. Mayo Professor I of neurosurgery at Mayo Clinic College of Medicine and Science. She is also one of the leaders of the Bioelectronics Neuromodulation Innovation to Cure (BIONIC) initiative, which aims to advance care for complex neurological conditions by uniting clinical insight with cutting-edge engineering to deliver novel diagnostics and therapies.
In this conversation, Dr. Zadeh reflects on the path that led her to neurosurgery, what inspires her and why she believes the medical field is at a turning point in its ability to diagnose, treat and even prevent neurodegenerative diseases.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. newsnetwork.mayoclinic.org
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at newsnetwork.mayoclinic.org/request-account
Mayo Clinic: mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: facebook.com/MayoClinic
Follow Mayo Clinic on Instagram instagram.com/mayoclinic
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: threads.net/@mayoclinic
